technetium tc 99m sestamibi has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y | 1 |
| Brown, ML; Carty, SE; Clarke, MR; Perez-Monte, JE; Watson, CG | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2016 |
Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I.
Topics: Carcinoid Tumor; Female; Humans; Hyperparathyroidism; Middle Aged; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thymus Neoplasms; Tomography, Emission-Computed, Single-Photon | 1997 |